Compare CTLP & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTLP | THQ |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | 345 | N/A |
| Industry | EDP Services | Finance Companies |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 757.1M | 798.8M |
| IPO Year | N/A | N/A |
| Metric | CTLP | THQ |
|---|---|---|
| Price | $10.67 | $18.26 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 121.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.11 | N/A |
| Revenue Next Year | $14.37 | N/A |
| P/E Ratio | $13.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.01 | $15.14 |
| 52 Week High | $11.16 | $21.07 |
| Indicator | CTLP | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 60.92 | 37.61 |
| Support Level | $10.52 | $18.30 |
| Resistance Level | $10.77 | $18.72 |
| Average True Range (ATR) | 0.23 | 0.25 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 97.24 | 34.75 |
Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.